Brazilian President Jair Bolsonaro, addressing the nation last month in a video on social media, touted the latest in a string of unconventional drugs he says can ease the country's COVID-19 crisis.
Bolsonaro — a vaccine skeptic and promoter of discredited treatments such as hydroxychloroquine — said this new drug, Proxalutamide, would "soon be available to all Brazil." He invited a little-known Health Ministry official, Helio Angotti, to expand on its promise.
Angotti, an eye doctor with no epidemiological experience, cited a domestic Proxalutamide study showing a 92% decrease in mortality risk among hospitalized COVID-19 patients. It was a dramatic claim amid a global struggle to find effective treatments. He said he aimed to "get it to the Brazilian population as soon as possible."
With your current subscription plan you can comment on stories. However, before writing your first comment, please create a display name in the Profile section of your subscriber account page.